Sindbis viral vectors target hematopoietic malignant cells

Area of Science:

• Oncology
• Virology
• Gene Therapy

Background:

• Sindbis viral vectors are known to inhibit solid tumor growth in preclinical models.
• The efficacy of Sindbis vectors against hematological malignancies remains largely uncharacterized.

Purpose of the Study:

• To investigate the potential of Sindbis viral vectors in targeting and treating hematopoietic malignancies.
• To evaluate the infectivity and therapeutic efficacy of Sindbis vectors in mouse models of lymphoma and leukemia.

Main Methods:

• Sindbis vectors were used to infect and induce apoptosis in mouse BW5147 malignant hematopoietic T-cells and human lymphoid cell lines.
• Therapeutic efficacy was assessed by intraperitoneal injection of Sindbis vectors into tumor-bearing mice and a transgenic lymphoma model.

Main Results:

• Sindbis vectors efficiently infected mouse BW5147 cells and triggered apoptosis, significantly prolonging survival in tumor-bearing mice.
• Infection efficiency was low in human lymphoma and leukemia cell lines, suggesting additional factors influence Sindbis tropism beyond the laminin receptor.
• Therapeutic efficacy was observed in a mouse model, though infectivity was less efficient in a transgenic lymphoma model.

Conclusions:

• Sindbis viral vectors demonstrate potential for targeting and eliminating hematopoietic malignancies in murine models.
• Further investigation is required to elucidate the mechanisms governing the susceptibility of human lymphoid malignancies to Sindbis-based therapy.